The Effect of Kelussia odoratissima Mozaff Extract on SREBP-1C Gene Expression in Fatty Liver Rats and Healthy Rats

Studies have shown that Kelussia lowers low-density lipoprotein levels. Due to the increasing number of patients with fatty liver in this study, we aimed to investigate the effect of Kelussia extract on the expression of SREBP-1C gene in obese mice with fatty liver.

In the present study, 24 rats were divided into four groups: control, negative control, treatment and the second treatment. The two treatment groups received 400 and 800 ml/kg Kelussia extract by gavage, respectively. Rats were anesthetized with chloroform and after dissection, rat liver tissue was collected. Then RNA extraction and cDNA synthesis were performed. Finally, SREBP-1C gene expression was performed using RT-PCR Real time technique and relevant analyzes were performed.

In the present study, the results showed that Kelussia extract at a dose of 800 mg/kg could further reduce the expression of SREBP-1C gene than a dose of 400 mg/kg in rats with fatty liver. It is statistically significant compared to the patient group (p <0.05). The results of biochemical tests confirm liver improvement in treated rats at a dose of 800 mg/kg.
Discussion and

It seems that Kelussia extract reduces the expression of SREBP-1C gene due to its orange flavonoid, which plays an important role in the biogenesis of cholesterol, fatty acids and triglycerides. If approved in larger studies, it can be considered as a therapeutic target in fatty liver disease.